Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bullish | Bullish Swing Setup | 1.79% | |
| Overbought Stochastic | Strength | 1.79% | |
| Outside Day | Range Expansion | -0.52% | |
| Overbought Stochastic | Strength | -0.52% | |
| Gapped Down | Weakness | -0.52% | |
| Overbought Stochastic | Strength | 0.37% | |
| Stochastic Reached Overbought | Strength | 0.01% | |
| Inside Day | Range Contraction | 0.01% | |
| Overbought Stochastic | Strength | 0.01% | |
| Gapped Down | Weakness | 0.01% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Up 1% | about 3 hours ago |
| Gap Up Partially Closed | about 3 hours ago |
| Gapped Up (Partial) | about 3 hours ago |
| Rose Above 10 DMA | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 37.38 |
| 52 Week Low | 23.58 |
| Average Volume | 16,053 |
| 200-Day Moving Average | 30.01 |
| 50-Day Moving Average | 30.49 |
| 20-Day Moving Average | 31.33 |
| 10-Day Moving Average | 31.97 |
| Average True Range | 0.68 |
| RSI | 55.36 |
| ADX | 32.69 |
| +DI | 31.39 |
| -DI | 14.54 |
| Chandelier Exit (Long, 3 ATRs) | 30.74 |
| Chandelier Exit (Short, 3 ATRs) | 30.71 |
| Upper Bollinger Bands | 33.09 |
| Lower Bollinger Band | 29.58 |
| Percent B (%b) | 0.63 |
| BandWidth | 11.20 |
| MACD Line | 0.57 |
| MACD Signal Line | 0.52 |
| MACD Histogram | 0.0579 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.91 | ||||
| Resistance 3 (R3) | 33.00 | 32.72 | 32.73 | ||
| Resistance 2 (R2) | 32.72 | 32.44 | 32.68 | 32.66 | |
| Resistance 1 (R1) | 32.26 | 32.26 | 32.12 | 32.17 | 32.60 |
| Pivot Point | 31.98 | 31.98 | 31.91 | 31.94 | 31.98 |
| Support 1 (S1) | 31.52 | 31.70 | 31.38 | 31.43 | 31.00 |
| Support 2 (S2) | 31.24 | 31.52 | 31.20 | 30.94 | |
| Support 3 (S3) | 30.78 | 31.24 | 30.88 | ||
| Support 4 (S4) | 30.69 |
